The 4 analysts offering 12-month price forecasts for 89Bio Inc have a median target of 43.50, with a high estimate of 60.00 and a low estimate of 36.00. The median estimate represents a +27.12% increase from the last price of 34.22.
The current consensus among 4 polled investment analysts is to Buy stock in 89Bio Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.99
Reporting Date Feb 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.